Foley Advises Carna Health on Partnership with Renalytix to Advance Kidney Disease Management

Foley & Lardner LLP served as intellectual property counsel to Carna Health, an AI-enabled digital health company revolutionizing chronic disease prevention, in its partnership with Renalytix PLC (LSE: RENX) (OTCQB: RNLXY) to advance a novel, integrated approach to chronic kidney disease (CKD) management. The collaboration combines Renalytix’s FDA-approved kidneyintelX.dkd™ test with Carna Health’s AI-enabled digital […]